These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6124937)

  • 21. Bromazepam, a new anxiolytic: a comparative study with diazepam in general practice. Royal College of General Practitioners Medicines Surveillance Organisation.
    Royal College of General Practitioners Medicines Surveillance Organisation
    J R Coll Gen Pract; 1984 Sep; 34(266):509-12. PubMed ID: 6147412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bromazepam in out- and in-patient psychiatric practice.
    Rydzyński Z; Araszkiewicz A; Gruszczyński W
    Act Nerv Super (Praha); 1978 Dec; 20(4):248. PubMed ID: 32725
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparison of bromazepam and lorazepam in the treatment of neurotic depression].
    Ravenna C
    Clin Ter; 1980 Oct; 95(2):147-56. PubMed ID: 6110507
    [No Abstract]   [Full Text] [Related]  

  • 24. Bromazepam and diazepam in generalized anxiety: a placebo-controlled study with measurement of drug plasma concentrations.
    Fontaine R; Annable L; Chouinard G; Ogilvie RI
    J Clin Psychopharmacol; 1983 Apr; 3(2):80-7. PubMed ID: 6132936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical experience with bromazepam in endogenous depression].
    Náhunek K; Svestka J; Buresová A; Cesková E; Rysánek R; Novotná H
    Cesk Psychiatr; 1985 Aug; 81(4):235-41. PubMed ID: 2864140
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of a psychotropic drug in pedopsychiatric consultation (author's transl)].
    Baumgart-Durand C; Bovet-Du Bois N
    Schweiz Rundsch Med Prax; 1979 May; 68(21):679-82. PubMed ID: 36606
    [No Abstract]   [Full Text] [Related]  

  • 27. [Anxiety disorders in private practice psychiatric out-patients: prevalence, comorbidity and burden (DELTA study)].
    Pélissolo A; André C; Chignon JM; Dutoit D; Martin P; Richard-Berthe C; Tignol J
    Encephale; 2002; 28(6 Pt 1):510-9. PubMed ID: 12506263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental comparison of low doses of 1.5 mg fluspirilene and bromazepam in out-patients with psychovegetative disturbances.
    Hassel P
    Pharmacopsychiatry; 1985 Sep; 18(5):297-302. PubMed ID: 2864709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bromazepam in the treatment of somatized psychogenic disorders (author's transl)].
    Podiwinsky F; Jellinger K
    Wien Klin Wochenschr; 1979 Mar; 91(7):240-4. PubMed ID: 34934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bromazepam(Lexotan) and chlorprothixene(Taractan) in psychoneurotic anxiety states. A randomized, double-blind study from general practice concerning the effect, drug consumption, and risk of repeated treatment].
    Fynboe C; Christensen N; Halberg T; Hansen EA; Holm P; Knudsen JP; Lindhardt J; Maul B; Musaeus C; Nielsen MT; Schaumburg E
    Ugeskr Laeger; 1981 Oct; 143(41):2641-5. PubMed ID: 6117963
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparison of the therapeutic effect of bromazepam and chlorprothixene in depressive neuroses].
    Zapletálek M; Kudrnová K; Preiningerová O; Zapletálková J
    Cesk Psychiatr; 1982 Dec; 78(6):375-81. PubMed ID: 6129927
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH; Dunner DL
    Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical evaluation of Bromazepam with special reference to obsessive syndromes and phobias].
    De Giacomo P; Pierri G
    Acta Neurol (Napoli); 1974; 29(3):307-13. PubMed ID: 4153901
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy and withdrawal of two potent benzodiazepines: bromazepam and lorazepam.
    Fontaine R; Annable L; Beaudry P; Mercier P; Chouinard G
    Psychopharmacol Bull; 1985; 21(1):91-2. PubMed ID: 2858908
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative studies on the tranquilizer effect of fluspirilene and bromazepam].
    Thilmann J
    Med Welt; 1981 Dec; 32(51-52):1959-61. PubMed ID: 6120433
    [No Abstract]   [Full Text] [Related]  

  • 36. [Alprazolam (Tafil) and bromazepam (Lexotan) in the treatment of anxiety. A randomized, double-blind comparison in psychiatric outpatients].
    Sonne LM; Bruun-Hansen J
    Ugeskr Laeger; 1986 Jun; 148(23):1392-5. PubMed ID: 2873673
    [No Abstract]   [Full Text] [Related]  

  • 37. Bromazepam and diazepam in generalized anxiety: a placebo-controlled study of efficacy and withdrawal.
    Fontaine R; Chouinard G; Annable L
    Psychopharmacol Bull; 1984; 20(1):126-7. PubMed ID: 6144130
    [No Abstract]   [Full Text] [Related]  

  • 38. [Results of clinical trial of Ro-4-6270 in depressive-anxiety states].
    Ardito R; Paterni F
    Riv Neurobiol; 1967; 13(1):3-10. PubMed ID: 5602736
    [No Abstract]   [Full Text] [Related]  

  • 39. A double-blind test on the effect of bromazepam in obsessive-compulsive neurosis.
    Lin HN; Chen CC
    Taiwan Yi Xue Hui Za Zhi; 1979 Mar; 78(3):267-75. PubMed ID: 35583
    [No Abstract]   [Full Text] [Related]  

  • 40. A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults.
    Castaneda AE; Tuulio-Henriksson A; Marttunen M; Suvisaari J; Lönnqvist J
    J Affect Disord; 2008 Feb; 106(1-2):1-27. PubMed ID: 17707915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.